Literature DB >> 31097520

Tropism of influenza B viruses in human respiratory tract explants and airway organoids.

Christine H T Bui1,2, Renee W Y Chan3,2, Mandy M T Ng1, M-C Cheung1, Ka-Chun Ng1, Megan P K Chan1, Louisa L Y Chan1,3, Joanne H M Fong1, J M Nicholls4, J S Malik Peiris1, Michael C W Chan5.   

Abstract

Despite causing regular seasonal epidemics with substantial morbidity, mortality and socioeconomic burden, there is still a lack of research into influenza B viruses (IBVs). In this study, we provide for the first time a systematic investigation on the tropism, replication kinetics and pathogenesis of IBVs in the human respiratory tract.Physiologically relevant ex vivo explant cultures of human bronchus and lung, human airway organoids, and in vitro cultures of differentiated primary human bronchial epithelial cells and type-I-like alveolar epithelial cells were used to study the cellular and tissue tropism, replication competence and induced innate immune response of 16 IBV strains isolated from 1940 to 2012 in comparison with human seasonal influenza A viruses (IAVs), H1N1 and H3N2. IBVs from the diverged Yamagata- and Victoria-like lineages and the earlier undiverged period were included.The majority of IBVs replicated productively in human bronchus and lung with similar competence to seasonal IAVs. IBVs infected a variety of cell types, including ciliated cells, club cells, goblet cells and basal cells, in human airway organoids. Like seasonal IAVs, IBVs are low inducers of pro-inflammatory cytokines and chemokines. Most results suggested a higher preference for the conducting airway than the lower lung and strain-specific rather than lineage-specific pathogenicity of IBVs.Our results highlighted the non-negligible virulence of IBVs which require more attention and further investigation to alleviate the disease burden, especially when treatment options are limited.
Copyright ©ERS 2019.

Entities:  

Year:  2019        PMID: 31097520     DOI: 10.1183/13993003.00008-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  11 in total

1.  Generation of Human Lung Organoid Cultures from Healthy and Tumor Tissue to Study Infectious Diseases.

Authors:  Lorena Salgueiro; Susann Kummer; Vera Sonntag-Buck; Anne Weiß; Marc A Schneider; Hans-Georg Kräusslich; Rocio Sotillo
Journal:  J Virol       Date:  2022-03-14       Impact factor: 6.549

2.  Experimental Infection Using Mouse-Adapted Influenza B Virus in a Mouse Model.

Authors:  Elena Prokopyeva; Olga Kurskaya; Ivan Sobolev; Mariia Solomatina; Tatyana Murashkina; Anastasia Suvorova; Alexander Alekseev; Daria Danilenko; Andrey Komissarov; Artem Fadeev; Edward Ramsay; Alexander Shestopalov; Alexander Dygai; Kirill Sharshov
Journal:  Viruses       Date:  2020-04-21       Impact factor: 5.048

3.  Dissecting the Niche for Alveolar Type II Cells With Alveolar Organoids.

Authors:  Danying Liao; Huaibiao Li
Journal:  Front Cell Dev Biol       Date:  2020-06-04

4.  Apical-out airway organoids as a platform for studying viral infections and screening for antiviral drugs.

Authors:  Adithya Sridhar; Salvatore Simmini; Georgios Stroulios; Tyler Brown; Giulia Moreni; Douglas Kondro; Alessandro Dei; Allen Eaves; Sharon Louis; Juan Hou; Wing Chang; Dasja Pajkrt; Katja C Wolthers
Journal:  Sci Rep       Date:  2022-05-10       Impact factor: 4.996

Review 5.  3D Human Organoids: The Next "Viral" Model for the Molecular Basis of Infectious Diseases.

Authors:  Shirley Pei Shan Chia; Sharleen Li Ying Kong; Jeremy Kah Sheng Pang; Boon-Seng Soh
Journal:  Biomedicines       Date:  2022-06-28

6.  Suppression of influenza virus infection by rhinovirus interference - at the population, individual and cellular levels.

Authors:  Kin P Tao; Marc K C Chong; Kathy Y Y Chan; Jason C S Pun; Joseph G S Tsun; Samuel M W Chow; Calvin S H Ng; Maggie H T Wang; Paul K S Chan; Albert M Li; Renee W Y Chan
Journal:  Curr Res Microb Sci       Date:  2022-06-18

7.  Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus.

Authors:  Mallory L Myers; John R Gallagher; De'Marcus D Woolfork; Regan K Stradtmann-Carvalho; Samantha Maldonado-Puga; Kevin W Bock; Seyhan Boyoglu-Barnum; Hubza Syeda; Adrian Creanga; Derron A Alves; Masaru Kanekiyo; Audray K Harris
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786

Review 8.  State of the art on lung organoids in mammals.

Authors:  Fabienne Archer; Alexandra Bobet-Erny; Maryline Gomes
Journal:  Vet Res       Date:  2021-06-02       Impact factor: 3.683

9.  Identification of H3N2 NA and PB1-F2 genetic variants and their association with disease symptoms during the 2014-15 influenza season.

Authors:  Deena R Blumenkrantz; Thomas Mehoke; Kathryn Shaw-Saliba; Harrison Powell; Nicholas Wohlgemuth; Hsuan Liu; Elizabeth Macias; Jared Evans; Mitra Lewis; Rebecca Medina; Justin Hardick; Lauren M Sauer; Andrea Dugas; Anna DuVal; Andrew P Lane; Charlotte Gaydos; Richard Rothman; Peter Thielen; Andrew Pekosz
Journal:  Virus Evol       Date:  2021-06-04

10.  Airway and Alveoli Organoids as Valuable Research Tools in COVID-19.

Authors:  Miriane de Oliveira; Maria T De Sibio; Felipe A S Costa; Marna E Sakalem
Journal:  ACS Biomater Sci Eng       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.